Location History:
- San Francisco, CA (US) (2018 - 2021)
- Oakland, CA (US) (2023)
Company Filing History:
Years Active: 2018-2024
Title: Innovations by Daniel A Lim
Introduction
Daniel A Lim is an accomplished inventor based in San Francisco, CA. He holds a total of 4 patents that reflect his contributions to medical technology and therapeutic methods. His work has significantly impacted the fields of catheter design and cancer treatment.
Latest Patents
One of Lim's latest inventions is a microinjection catheter. This device serves as an insertion tool for delivering media inside a patient. It features an outer guide tube with a side port and an inner guide tube that is axially movable within the outer tube. The inner guide tube includes a deflector that allows the catheter to dispense its end outward through the outer guide tube when advanced. Additionally, a therapeutic delivery cannula can be nested within the catheter, guiding its direction into patient tissue. Another notable patent focuses on antisense therapies for treating cancers associated with a TERT promoter mutation. This invention outlines methods for administering agents that inhibit the expression or function of the GA binding protein transcription factor beta subunit 1 long isoform.
Career Highlights
Throughout his career, Lim has worked with prestigious institutions, including the University of California and the United States Government as represented by the Department of Veterans Affairs. His experience in these organizations has allowed him to develop innovative solutions in the medical field.
Collaborations
Lim has collaborated with notable colleagues such as Matthew Silvestrini and Tejal Ashwin Desai. Their combined expertise has contributed to the advancement of his inventions and research.
Conclusion
Daniel A Lim's innovative work in medical technology and cancer treatment showcases his dedication to improving patient care. His patents reflect a commitment to advancing healthcare solutions through inventive design and therapeutic methods.